Literature DB >> 2538615

Orally administered enalapril for infants with congestive heart failure: a dose-finding study.

T R Lloyd1, L T Mahoney, D Knoedel, W J Marvin, J E Robillard, R M Lauer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2538615     DOI： 10.1016/s0022-3476(89)80715-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  11 in total

1.  Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies.

Authors:  Mohsin Ali; Jutta Tins; Bjoern B Burckhardt
Journal:  AAPS J       Date:  2019-09-04       Impact factor: 4.009

2.  Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies).

Authors:  Stephanie Laeer; Willi Cawello; Bjoern B Burckhardt; László Ablonczy; Milica Bajcetic; Johannes M P J Breur; Michiel Dalinghaus; Christoph Male; Saskia N de Wildt; Jörg Breitkreutz; Muhammed Faisal; Anne Keatley-Clarke; Ingrid Klingmann; Florian B Lagler
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

Review 3.  ACE inhibitors in pediatric patients with heart failure.

Authors:  Kazuo Momma
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Enalapril-induced acute renal failure in a newborn infant.

Authors:  Sourabh Dutta; Anil Narang
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

5.  Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts.

Authors:  M W Webster; J M Neutze; A L Calder
Journal:  Pediatr Cardiol       Date:  1992-07       Impact factor: 1.655

6.  Tailored Assays for Pharmacokinetic and Pharmacodynamic Investigations of Aliskiren and Enalapril in Children: An Application in Serum, Urine, and Saliva.

Authors:  Bjoern B Burckhardt; Jutta Tins; Sergej Ramusovic; Stephanie Läer
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Nov-Dec

7.  Efficacy and dosage of enalapril in congenital and acquired heart disease.

Authors:  A M Leversha; N J Wilson; P M Clarkson; A L Calder; M C Ramage; J M Neutze
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791

8.  Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure.

Authors:  J P Dutertre; E M Billaud; E Autret; A Chantepie; I Oliver; J Laugier
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

9.  Sample Preparation and Extraction in Small Sample Volumes Suitable for Pediatric Clinical Studies: Challenges, Advances, and Experiences of a Bioanalytical HPLC-MS/MS Method Validation Using Enalapril and Enalaprilat.

Authors:  Bjoern B Burckhardt; Stephanie Laeer
Journal:  Int J Anal Chem       Date:  2015-03-19       Impact factor: 1.885

10.  Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study.

Authors:  Milica Bajcetic; Saskia N de Wildt; Michiel Dalinghaus; Jörg Breitkreutz; Ingrid Klingmann; Florian B Lagler; Anne Keatley-Clarke; Johannes Mpj Breur; Christoph Male; Ida Jovanovic; Andras Szatmári; László Ablonczy; Bjoern B Burckhardt; Willi Cawello; Karl Kleine; Emina Obarcanin; Lucie Spatenkova; Vanessa Swoboda; Marijke van der Meulen; Peter Wagner; Jennifer Walsh; Stephanie Läer
Journal:  Contemp Clin Trials Commun       Date:  2019-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.